Recent Investment Analysts’ Ratings Changes for Acadia Healthcare (ACHC)

A number of firms have modified their ratings and price targets on shares of Acadia Healthcare (NASDAQ: ACHC) recently:

• 1/22/2026 – Acadia Healthcare was downgraded by analysts at Jefferies Financial Group Inc. to a “hold” rating.
• 1/22/2026 – Acadia Healthcare had its “hold” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $15.00 price target on the stock, down previously from $34.00.
• 1/21/2026 – Acadia Healthcare had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings.
• 1/16/2026 – Acadia Healthcare had its “reduce” rating reaffirmed by analysts at TD Cowen.
• 1/16/2026 – Acadia Healthcare had its price target lowered by analysts at TD Cowen from $25.00 to $22.00. They now have a “buy” rating on the stock.
• 1/14/2026 – Acadia Healthcare had its price target lowered by analysts at Royal Bank Of Canada from $19.00 to $17.00. They now have an “outperform” rating on the stock.
• 12/18/2025 – Acadia Healthcare had its price target lowered by analysts at Mizuho from $22.00 to $17.00. They now have a “neutral” rating on the stock.

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.